Carlyle Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Carlyle Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-96,419	Closed	-$3.68M	–	24
2016 Q2	$3.68M	Sell	96,419 -59,045	-38%	-$2.59M	0.06%	24
2016 Q1	$6.41M	Hold	155,464	–	–	0.08%	23
2015 Q4	$7.54M	Sell	155,464 -66,521	-30%	-$2.96M	0.1%	25
2015 Q3	$8.88M	Sell	221,985 -58,811	-21%	-$2.57M	0.06%	23
2015 Q2	$11.3M	Sell	280,796 -94,648	-25%	-$3.27M	0.07%	24
2015 Q1	$12.3M	Hold	375,444	–	–	0.06%	24
2014 Q4	$9.64M	Buy	+375,444	New	+$8.93M	0.06%	27

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carlyle Group's SYNH Position: Q3 2016 in Review

Carlyle Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2016, closing a stake of 96,419 shares — an estimated $3.68M sold.

Carlyle Group first reported a position in SYNH in Q4 2014 and held it in 7 quarters. The position peaked at $12.3M in Q1 2015. 237 funds tracked by Wall St. Rank hold SYNH as of Q3 2016.

Carlyle Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2016 after selling out during the quarter.
Carlyle Group sold 96,419 Syneos Health, Inc. Class A Common Stock shares in Q3 2016, an estimated $3.68M.
Carlyle Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 7 quarters.
Carlyle Group's Syneos Health, Inc. Class A Common Stock position peaked at $12.3M in Q1 2015.
237 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2016.

Based on Carlyle Group's 13F filing for Q3 2016, filed 14 Nov 2016.